美国脊髓星形细胞瘤综合流行病学综述
该研究基于美国中枢脑肿瘤登记处(CBTRUS)1995至2016年数据,分析脊髓星形细胞瘤(SCA)的流行病学特征。发病率在0-19岁年龄组达峰值0.064,男性高于女性,亚洲/太平洋岛民及西班牙裔患者发病率显著较低,WHO I级SCA发病率显著高于更高级别。
要点
- SCA总体AAI为0.047/10万,男性0.053显著高于女性0.041。
- 0-19岁年龄组发病率峰值0.064,男性20-34岁、女性35-44岁达低谷。
- 亚洲/太平洋岛民及西班牙裔患者SCA发病率显著较低。
核心结论
- 1995至2016年美国SCA总体AAI为0.047/10万,男性发病率高于女性。
- SCA发病率在生命早期达峰,男性20-34岁、女性35-44岁降至低谷后缓慢上升。
- 毛细胞型星形细胞瘤是研究队列中最常见的SCA。
研究设计与样本
- 基于美国中枢脑肿瘤登记处(CBTRUS)的流行病学研究。
- 查询ICD-O-3组织学和拓扑学编码获取SCA病例。
- 计算年龄调整发病率(AAI)并按种族、性别、年龄和族裔分层。
- 使用Joinpoint计算发病率的年度百分比变化(APC)。
主要发现
- 总体AAI为0.047(95%CI 0.045-0.049)。
- 0-19岁年龄组发病率峰值0.064(95%CI 0.060-0.067)。
- 男性发病率0.053(95%CI 0.050-0.055)显著高于女性0.041(95%CI 0.039-0.044)。
- 亚洲/太平洋岛民AAI为0.034(95%CI 0.028-0.042,p=0.00015),西班牙裔AAI为0.035(95%CI 0.031-0.039,p<0.001),均显著较低。
关键数值与推荐
- SCA总体AAI为0.047/10万(95%CI 0.045-0.049)。
- 男性AAI为0.053(95%CI 0.050-0.055),女性为0.041(95%CI 0.039-0.044)。
- 0-19岁年龄组AAI峰值0.064(95%CI 0.060-0.067)。
- 亚洲/太平洋岛民AAI为0.034(95%CI 0.028-0.042,p=0.00015)。
- 西班牙裔AAI为0.035(95%CI 0.031-0.039,p<0.001)。
临床怎么用
- 为神经外科医生提供美国SCA发病率的基线流行病学数据。
- 提示男性及年轻患者SCA发病率较高,需关注相应人群的筛查与诊断。
- 不同种族和族裔发病率存在差异,临床评估时应考虑人口学特征。
- WHO I级SCA发病率最高,提示低级别肿瘤在SCA中占主导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spinal cord astrocytoma (SCA) is a rare tumor whose epidemiology has not been well defined. The authors utilized the Central Brain Tumor Registry of the United States (CBTRUS) to provide comprehensive up-to-date epidemiological data for this disease. METHODS: The CBTRUS was queried for SCAs on ICD-O-3 (International Classification of Diseases for Oncology, 3rd edition) histological and topographical codes. The age-adjusted incidence (AAI) per 100,000 persons was calculated and stratified by race, sex, age, and ethnicity. Joinpoint was used to calculate the annual percentage change (APC) in incidence. RESULTS: Two thousand nine hundred sixty-nine SCAs were diagnosed in the US between 1995 and 2016, resulting in an average of approximately 136 SCAs annually. The overall AAI was 0.047 (95% CI 0.045-0.049), and there was a statistically significant increase from 0.051 in 1995 to 0.043 in 2016. The peak incidence of 0.064 (95% CI 0.060-0.067) was found in the 0- to 19-year age group. The incidence in males was 0.053 (95% CI 0.050-0.055), which was significantly greater than the incidence in females (0.041, 95% CI 0.039-0.044). SCA incidence was significantly lower both in patients of Asian/Pacific Islander race (AAI = 0.034, 95% CI 0.028-0.042, p = 0.00015) and in patients of Hispanic ethnicity (AAI = 0.035, 95% CI 0.031-0.039, p < 0.001). The incidence of WHO grade I SCAs was significantly higher than those of WHO grade II, III, or IV SCAs (p < 0.001). CONCLUSIONS: The overall AAI of SCA from 1995 to 2016 was 0.047 per 100,000. The incidence peaked early in life for both sexes, reached a nadir between 20 and 34 years of age for males and between 35 and 44 years of age for females, and then slowly increased throughout adulthood, with a greater incidence in males. Pilocytic astrocytomas were the most common SCA in the study cohort. This study presents the most comprehensive epidemiological study of SCA incidence in the US to date.
引用
- Shao J, Jones J, Ellsworth P, et al. A comprehensive epidemiological review of spinal astrocytomas in the United States. J Neurosurg Spine. 2020. PMID: 33157530. doi:10.3171/2020.6.SPINE191532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。